What is ICER and how does it impact your patients?
Many allergists are not fully aware that there is another contributor to how patients access medication we prescribe: ICER.
New! Audit Toolkit
Learn how to respond to an insurance carrier’s audit, plus how and why to perform an internal audit.
The importance of parameters
The College recently was a key expert organization contributing to the latest practice parameters in allergy/immunology.
Information Blocking
The ONC has not enforced or issued penalties for physicians violating the information blocking prohibition – until now.
Tips for a profitable, safe and compliant practice in 2024
The Practice Management Committee has outlined 10 key things every allergy and immunology practice should do to be profitable, safe, prepared and in compliance…
Update your fee schedule to maximize revenue 2024
If you haven’t reviewed and updated your fee schedule in the past year, you might be leaving revenue on the table.
January 2024 Annals highlights
Our focus this issue is on pediatric and adolescent asthma. The CME Review focuses on the use of biologics in pediatric asthma and its future.
What were you reading in 2023?
We’ll continue to provide members with important information via Insider – and our other publications and emails – in 2024.
2024 Final Medicare Physician Fee Schedule
CMS released its final rule updating the Medicare physician fee schedule for calendar year 2024 (Final Rule).
PBMs – how influential are they?
Many of us were shocked by the news that GlaxoSmithKline (GSK) Pharmaceuticals withdrew Flovent from the U.S. market at the end of 2023.